TY - JOUR
T1 - Effects of Growth Hormone Treatment on Lipid Profiles
AU - Kubo, Toshihide
AU - Furujo, Mahoko
AU - Takahashi, Kyohei
AU - Hyodo, Yuki
AU - Tsuchiya, Hiroki
AU - Hattori, Mariko
AU - Fujinaga, Shoko
AU - Urayama, Kenji
N1 - Funding Information:
Supported by National Hospital Organization, Okayama
Publisher Copyright:
© 2017, Dr. K C Chaudhuri Foundation.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Objectives: To assess the effects of growth hormone (GH) on lipid profiles in children and whether the effect is pharmacological. Methods: The authors determined serum levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and low-density lipoprotein cholesterol (LDL-C) every year during 3-y GH treatment in 48 GH deficient (GHD) short children and 22 children with short stature born small for gestational age (SGA). Results: The abnormally high levels of TC, non-HDL-C, and LDL-C showed a high frequency in GHD short children compared with epidemiological studies in Japan. The high prevalence of high level of TC was also shown in SGA short children. Three-year GH treatment decreased serum TC, non-HDL-C, and LDL-C levels in both patient groups. Conclusions: GH treatment is clearly a pharmacological therapy in SGA short children and so may also be in GHD short children at the Japanese standard therapeutic dose. Taken together, GH improves lipid profiles, and its effect has the possibility of medical properties.
AB - Objectives: To assess the effects of growth hormone (GH) on lipid profiles in children and whether the effect is pharmacological. Methods: The authors determined serum levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and low-density lipoprotein cholesterol (LDL-C) every year during 3-y GH treatment in 48 GH deficient (GHD) short children and 22 children with short stature born small for gestational age (SGA). Results: The abnormally high levels of TC, non-HDL-C, and LDL-C showed a high frequency in GHD short children compared with epidemiological studies in Japan. The high prevalence of high level of TC was also shown in SGA short children. Three-year GH treatment decreased serum TC, non-HDL-C, and LDL-C levels in both patient groups. Conclusions: GH treatment is clearly a pharmacological therapy in SGA short children and so may also be in GHD short children at the Japanese standard therapeutic dose. Taken together, GH improves lipid profiles, and its effect has the possibility of medical properties.
KW - Cholesterol
KW - Growth hormone
KW - Growth hormone deficiency
KW - Lipid
KW - Small for gestational age
UR - http://www.scopus.com/inward/record.url?scp=85033438576&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033438576&partnerID=8YFLogxK
U2 - 10.1007/s12098-017-2509-8
DO - 10.1007/s12098-017-2509-8
M3 - Article
C2 - 29127617
AN - SCOPUS:85033438576
SN - 0019-5456
VL - 85
SP - 261
EP - 265
JO - Indian Journal of Pediatrics
JF - Indian Journal of Pediatrics
IS - 4
ER -